The newly established Innovation Advisory Board is made up of eight esteemed international experts, each providing EP PerMed with invaluable strategic advice and expertise to accelerate innovation in personalised medicine.
Driving innovation forward
The Innovation Advisory Board brings together crucial expertise to identify the key needs within the personalised medicine system to accelerate innovation. EP PerMed will be supported by the newly established board in identifying existing offers, tools, and best practices for supporting the innovation of promising personalised medicine projects and initiatives. By leveraging the collective expertise of the board members, promising projects with the potential to advance to higher technology readiness levels will be recognized. Further, the Innovation Advisory Board will advise on and contribute to innovation-related events within EP PerMed, such as round tables and hackathons, and provide valuable input to the Strategic Research and Innovation Agenda (SRIA).
Meet the experts
EP PerMed is proud to have assembled a diverse group of experts from the following fields for the Innovation Advisory Board, each contributing their unique perspectives to shape the future of personalised medicine:
- Biomedical research
- Business development & market access
- Clinical research & development
- Digital technology, data & AI
- Health economy, health technology assessment & intellectual property
- Regulatory framework & ELSA
- Patient perspective & patient engagement
Maria Laura García Bermejo
- Scientific director at Ramon & Cajal Health Research Institute (IRYCIS, Spain)
- Spain and European infrastructure for translational medicine (EATRIS)
Jenni Nordborg
- Director of International affairs at Lif, the Research-Based Pharmaceutical Industry (Sweden)
- Former senior management at Swedish government and VINNOVA
Joanne Hackett
- Head of Genomic and Precision Medicine, at IQVIA (UK)
- Former CCO at Genomics England
Erwin Sablon
- Head of Business Development/Expert Scientist Diagnostics & Biomarkers, at VIB (Belgium)
Sander Pajusalu
- Head of the Genetics and Personalized Medicine and Senior Medical Geneticist at Tartu University Hospital (Estonia)
- Vice Dean and Associate Professor at the University of Tartu Faculty of Medicine
Fátima Al-Shahrour
- Head of the Bioinformatics Unit at the Spanish National Cancer Research Centre
Anne Cambon-Thomsen
- Doctor, Emeritus Research Director at the Centre National de la Recherche Scientifique (France)
- Former Director-Coordinator of the ELSI joint service of BBMRI-ERIC
Romain Alderweireldt
- Lawyer, specialized in telecoms and pharmaceutical competition law at CMS Brussels (Belgium)
- Founder of 101 Genomes foundation